QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
Log in
NYSE:ALC

Alcon Stock Forecast, Price & News

$56.89
+0.09 (+0.16 %)
(As of 09/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$56.57
Now: $56.89
$57.59
50-Day Range
$55.23
MA: $58.10
$61.96
52-Week Range
$39.37
Now: $56.89
$65.37
Volume823,908 shs
Average Volume1.35 million shs
Market Capitalization$27.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.52
Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. It offers surgical products, which include technologies and devices for cataract, retinal, glaucoma, and refractive surgery; advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism; and advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery. The company also provides pharmaceutical products for elevated intraocular pressure caused by glaucoma; anti-inflammatories; anti-infective to aid in the treatment of bacterial infections and bacterial conjunctivitis; ophthalmic solutions to treat inflammation and pain associated with ocular surgery; eye inflammation and infection solutions following cataract surgery; and vitreomacular adhesion, eye and nasal allergy treatment solutions, and over-the-counter dry eye relief and ocular vitamins. In addition, it offers vision care products, such as contact lenses and lens care products; daily disposable, monthly replacement, and color-enhancing contact lenses for comfortable and convenient vision correction options; contact lens care products; multi-purpose and hydrogen-peroxide based solutions to clean, rinse, and disinfect contact lenses; rewetting drops; and daily protein removers that removes protein deposits from lenses. Alcon, Inc. was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Fort Worth, Texas. Alcon, Inc. was previously operating as a subsidiary of Novartis AG. Alcon, Inc.(SWX:ALC) operates independently of Novartis AG as of April 9, 2019.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP04544X30
Phone41-58-911-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.51 billion
Cash Flow$4.93 per share
Book Value$39.54 per share

Profitability

Net Income$-656,000,000.00

Miscellaneous

Employees22,142
Market Cap$27.77 billion
Next Earnings Date11/17/2020 (Estimated)
OptionableNot Optionable
$56.89
+0.09 (+0.16 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALC News and Ratings via Email

Sign-up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Alcon (NYSE:ALC) Frequently Asked Questions

How has Alcon's stock been impacted by COVID-19?

Alcon's stock was trading at $54.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALC stock has increased by 5.0% and is now trading at $56.89.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Alcon?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 4 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Alcon
.

When is Alcon's next earnings date?

Alcon is scheduled to release its next quarterly earnings announcement on Tuesday, November 17th 2020.
View our earnings forecast for Alcon
.

How were Alcon's earnings last quarter?

Alcon AG (NYSE:ALC) released its quarterly earnings results on Tuesday, August, 18th. The healthcare company reported ($0.21) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.06. The healthcare company had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.21 billion. Alcon had a positive return on equity of 2.94% and a negative net margin of 9.30%. Alcon's quarterly revenue was down 35.7% on a year-over-year basis.
View Alcon's earnings history
.

What price target have analysts set for ALC?

17 equities research analysts have issued twelve-month target prices for Alcon's shares. Their forecasts range from $50.00 to $68.00. On average, they expect Alcon's share price to reach $59.78 in the next year. This suggests a possible upside of 5.1% from the stock's current price.
View analysts' price targets for Alcon
.

Are investors shorting Alcon?

Alcon saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 5,620,000 shares, a decrease of 16.4% from the August 31st total of 6,720,000 shares. Based on an average trading volume of 1,280,000 shares, the short-interest ratio is presently 4.4 days. Approximately 1.2% of the company's stock are short sold.
View Alcon's Short Interest
.

Who are some of Alcon's key competitors?

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), IBM (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), AbbVie (ABBV) and Chevron (CVX).

Who are Alcon's key executives?

Alcon's management team includes the following people:
  • Mr. Merrick McCracken, Sr. VP of HR
  • Mr. Ed McGough, Sr. VP of Global Manufacturing and Technical Operations (Age 58)
  • Mr. David J. Endicott, Chief Exec. Officer (Age 54)
  • Mr. David Murray, Chief Financial Officer
  • Mr. Allen Baker, Chief Operating Officer and Exec. VP

What is Alcon's stock symbol?

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

How do I buy shares of Alcon?

Shares of ALC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alcon's stock price today?

One share of ALC stock can currently be purchased for approximately $56.89.

How big of a company is Alcon?

Alcon has a market capitalization of $27.77 billion and generates $7.51 billion in revenue each year. The healthcare company earns $-656,000,000.00 in net income (profit) each year or $1.89 on an earnings per share basis. Alcon employs 22,142 workers across the globe.

What is Alcon's official website?

The official website for Alcon is www.alcon.com.

How can I contact Alcon?

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The healthcare company can be reached via phone at 41-58-911-2000 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.